Ordering
Available Variants250 mg
CHA.97803-250mg
Price
€106.40
Available – Dispatch in 14 days
1 g
CHA.97803-1g
Price
€356.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
250 mg | CHA.97803-250mg | €106.40 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 g | CHA.97803-1g | €356.80 |
≥98% (TLC), crystals, nicotine metabolite
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C10H12N2O |
|---|---|
| CAS Number | 486-56-6 |
| Molecular Weight | 176.22 |
| NACRES | NA.77 |
| PubChem Substance ID | 24278324 |
| UNSPSC Code | 12352200 |
| EC Number | 207-634-9 |
| MDL number | MFCD00077696 |
| Beilstein/REAXYS Number | 83099 |
| Assay | ≥98% |
| Form | crystals |
| Quality level | 200 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302,H315,H319,H335 |
| pcodes | P261 - P264 - P270 - P301 + P312 - P302 + P352 - P305 + P351 + P338 |
| Hazard Classifications | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| target_organs | Respiratory system |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | 230.0 °F - closed cup |
| flash_point_c | 110 °C - closed cup |
| ppe | dust mask type N95 (US), Eyeshields, Gloves |
Technical Overview & Applications Use-case context
(−)-Cotinine, with the CAS number 486-56-6, is a major metabolite of nicotine and a well-established biomarker for exposure to tobacco smoke. As a secondary amine, it is formed through the cytochrome P450-mediated oxidation of nicotine. (−)-Cotinine has been extensively studied due to its potential applications in smoking cessation therapies and its role in understanding nicotine addiction. Its pharmacokinetic properties, including a half-life of approximately 20 hours, make it a reliable indicator of recent nicotine exposure. The measurement of (−)-Cotinine levels in biological fluids, such as blood, urine, or saliva, is commonly used to assess tobacco smoke exposure and to monitor smoking cessation efforts. This compound has also been investigated for its potential therapeutic effects, including neuroprotective and anti-inflammatory properties.
